Polyacrylamide hydrogel differences: getting rid of the confusion.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Drugs in Dermatology

• Publication date

  2011-12-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  PMID 22134560
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early and late complications of polyalkylimide gel (Bio-Alcamid)®.

  2011cited by this paper
• Surgical correction of HIV-associated facial lipoatrophy

  2011cited by this paper
• 12‐Month Controlled Study in the United States of the Safety and Efficacy of a Permanent 2.5% Polyacrylamide Hydrogel Soft‐Tissue Filler

  2010cited by this paper
• A 5-Year Assessment of Safety and Aesthetic Results after Facial Soft-Tissue Augmentation with Polyacrylamide Hydrogel (Aquamid): A Prospective Multicenter Study of 251 Patients

  2010cited by this paper
• Complications after Polyacrylamide Hydrogel Injection for Soft-Tissue Augmentation

  2010cited by this paper
• Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophy

  2009cited by this paper
• Complications after Treatment with Polyalkylimide

  2009cited by this paper
• Long-Term Orbitofacial Complications of Polyalkylimide 4% (Bio-Alcamid)

  2009cited by this paper
• Four-Year Safety with Polyacrylamide Hydrogel to Correct Antiretroviral-Related Facial Lipoatrophy

  2009cited by this paper
• Detection of Bacteria by Fluorescence in Situ Hybridization in Culture‐Negative Soft Tissue Filler Lesions

  2009cited by this paper
• Cheek Augmentation With Bio-Alcamid in Facial Lipoatrophy in HIV Seropositive Patients

  2008cited by this paper
• Long-Term Effect of Polyalkylimide Gel Injections on Severity of Facial Lipoatrophy and Quality of Life of HIV-Positive Patients

  2008cited by this paper
• Polyacrylamide Hydrogel Injection in the Management of Human Immunodeficiency Virus–Related Facial Lipoatrophy: A 2-Year Clinical Experience

  2008cited by this paper
• Tissue Integration of Polyacrylamide Hydrogel: An Experimental Study of Periurethral, Perivesical, and Mammary Gland Tissue in the Pig

  2008cited by this paper
• Preliminary Experiences with Bio-Alcamid in HIV Facial Lipoatrophy

  2007cited by this paper
• Experience with Bio-Alcamid, a new soft tissue endoprosthesis.

  2007cited by this paper
• Complications from Repeated Injection or Puncture of Old Polyacrylamide Gel Implant Sites: Case Reports

  2007cited by this paper
• Migration of Implants: A Problem with Injectable Polyacrylamide Gel in Aesthetic Plastic Surgery

  2006cited by this paper
• Complications of polyalkylimide 4% injections (Bio-Alcamid): a report of 18 cases.

  2006cited by this paper
• Late Complications After Polyacrylamide Hydrogel Injection into Facial Soft Tissues

  2006cited by this paper
• In vitro and in vivo biocompatibility evaluation of a polyalkylimide hydrogel for soft tissue augmentation.

  2005cited by this paper
• Parry-Romberg syndrome.

  2005cited by this paper
• Bio-Alcamid: an electron microscopic study after skin implantation.

  2004cited by this paper
• Unfavorable findings following breast augmentation using injected polyacrylamide hydrogel.

  2004cited by this paper
• The polyalkylimide gel: experience with Bio-Alcamid.

  2004cited by this paper
• Clinical and Histologic Evaluation of a New Injectable Implant:: Hydrophilic Polyacrylamide Gel

  2004cited by this paper
• Biocompatibility and Tissue Interactions of a New Filler Material for Medical Use

  2004cited by this paper
• Long‐Term Effects of Polyacrylamide Hydrogel on Human Breast Tissue

  2003cited by this paper
• Bio-Alcamid, a novel prosthetic polymer, does not interfere with morphological and functional characteristics of human skin fibroblasts.

  2003cited by this paper
• Complications of Breast Augmentation with Injected Hydrophilic Polyacrylamide Gel

  2002cited by this paper

• A Safety and Efficacy Study of a Synthetic Biolubricant in an Equine Model of Post-Traumatic Osteoarthritis

  2025cites this paper
• Review of intra‐articular 2.5% polyacrylamide hydrogel, a new concept in the management of osteoarthritis

  2024cites this paper
• Histologic and cytologic changes in normal equine joints after injection with 2.5% injectable polyacrylamide hydrogel reveal low-level macrophage-driven foreign body response.

  2024influential citation
• A review of complications of polyacrylamide hydrogel injection

  2022cites this paper
• A Systematic Review of the Novel Compound Arthrosamid Polyacrylamide (PAAG) Hydrogel for Treatment of Knee Osteoarthritis

  2022cites this paper
• Intra-articular 2.5% polyacrylamide hydrogel, a new concept in the medication of equine osteoarthritis: A review.

  2022cites this paper
• Use of a 2.5% Cross-Linked Polyacrylamide Hydrogel in the Management of Joint Lameness in a Population of Flat Racing Thoroughbreds: A Pilot Study.

  2019cites this paper
• Polyacrylamide Hydrogel as a Bulking Agent for the Endoscopic Treatment of Vesicoureteral Reflux: Long‐Term Results and Safety

  2017cites this paper